G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Senior Manager, Data/AI Solution Architect

Natural Language Processing & LLMsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A Bachelor's degree and eight years of experience, or a Master's degree and six years of experience.
  • At least five years of experience in AI/ML engineering, with hands-on experience building large language model or generative AI applications, including fine-tuning, retrieval-augmented generation, and prompt engineering.
  • Strong programming skills in Python and modern machine learning frameworks.
  • Experience designing knowledge bases and retrieval systems over large structured and unstructured sources.
  • Experience with AWS cloud AI platforms and MLOps tooling.
  • Solid data engineering fundamentals, including pipelines, data modeling, and large-scale processing.
  • Experience delivering a portfolio of solutions across multiple business functions, including leading delivery through engineering teams and external partners.
  • Experience in pharmaceutical, biotech, life sciences, or other highly regulated industries.
  • Familiarity with technology policies, compliance, and governance workflows in a regulated enterprise environment.
  • Experience with enterprise context building and automation.
  • Experience handling confidential and sensitive enterprise data, including HR and Legal data, with appropriate privacy controls.
  • Experience with responsible AI, model governance, and validation in regulated environments.

Responsibilities

  • Partner with business process leads across HR, Compliance, and Legal to assess needs, translate them into practical AI solution designs, and serve as the technical lead across solutions.
  • Build, fine-tune, and evaluate AI and large language models grounded in policy, procedural, and regulatory requirements and adaptable to company-specific content, internal materials, and approved templates.
  • Design and maintain retrieval-augmented knowledge bases incorporating authoritative external guidance, corporate policy libraries, compliance frameworks and codes of conduct, and company-specific documentation.
  • Develop reusable capabilities for document review, summarization, consistency and policy-alignment checking, citation accuracy, and risk flagging, with traceable citations back to source content.
  • Engineer secure, scalable ingestion and processing pipelines for diverse enterprise support content, including policy and procedure documents, employee-facing communications, training and enablement materials, internal narratives, external publications, and structured business records.
  • Direct execution through engineers, vendor partners, and shared platform resources by setting technical direction, reviewing designs, ensuring quality, and driving solutions to production at a scale beyond individual delivery.
  • Establish evaluation frameworks, accuracy benchmarks, guardrails, and human-in-the-loop validation to ensure trustworthy, defensible, and auditable outputs.
  • Bridge business stakeholders and AI delivery by translating functional review and knowledge-work needs into trusted, auditable solutions that reduce cycle time and organizational risk; drive adoption, enablement, and change management.
  • Ensure solutions meet data privacy, confidentiality, security, and responsible AI standards, with role-based access appropriate to sensitive enterprise content.
  • Implement model deployment, monitoring, versioning, and continuous improvement practices, and establish reusable architecture standards and delivery patterns across the portfolio.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs